KMC
RPRX icon

Kirr Marbach & Co’s Royalty Pharma RPRX Stock Holding History

Kirr Marbach & Co’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Buy
239,461
+1,566
+0.7% +$81.5K 2.26% 14
2026
Q1 		$11.4M Buy
+237,895
New +$10.4M 2.08% 19

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Kirr Marbach & Co's RPRX Position: Q2 2026 in Review

Kirr Marbach & Co increased its Royalty Pharma (RPRX) stake by 0.66% in Q2 2026, buying an estimated $81.5K and bringing the position to 239,461 shares worth $13.4M. The position accounts for 2.26% of the portfolio, ranked #14.

Kirr Marbach & Co first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Kirr Marbach & Co held 239,461 shares of Royalty Pharma worth $13.4M as of Q2 2026.
  • Kirr Marbach & Co bought 1,566 Royalty Pharma shares in Q2 2026, an estimated $81.5K.
  • Royalty Pharma made up 2.26% of Kirr Marbach & Co's portfolio in Q2 2026, its #14 holding.
  • Kirr Marbach & Co first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 183 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Kirr Marbach & Co's 13F filing for Q2 2026, filed 14 Jul 2026.